On November 15, 2024, the team led by Dr. Cao Yu from Shanghai Ninth People's Hospital affiliated with Shanghai Jiao Tong University School of Medicine, in collaboration with Dr. Yu Ye’s team from China Pharmaceutical University, published a research paper in Science titled “Structural basis for inositol pyrophosphate gating of the phosphate channel XPR1.” This study utilizes cutting-edge cr...

On December 5, 2024 (Beijing time), Dengli Hong's research group from the College of Basic Medical Sciences, Shanghai Jiao Tong University, published a groundbreaking article in Nature titled "Fetal hepatocytes protect the HSPC genome via fetuin-A."The study reveals the mechanism of embryonic tissues protect the genomic stability of their stem cells and demonstrates that this mechanism is relat...

Recently, Professor Wang Hui and Dr Cheong Io Hong’s team from Shanghai Jiao Tong University School of Public Health collaborated with World Health Organization (WHO) experts to write a chapter titled "Digital Healthcare: Population-Level Applications" in the book Digitalization of Medicine in Low- and Middle-Income Countries, published by Springer as part of the United Nations Sustainable Dev...

On the evening of November 16, 2024, Beijing time, the centennial celebration and 2024 Scientific Sessions of American Heart Association (AHA) were held in Chicago. Ning Guang, President of Ruijin Hospital Affiliated with Shanghai Jiao Tong University School of Medicine and Academician of Chinese Academy of Engineering, presented the opening report on behalf of the research team led by Professo...

On July 24, CAI Yujia’s team from Shanghai Jiao Tong University and Søren R Paludan’s team from Aarhus University in Denmark jointly published a groundbreaking research article in Nature (with Shanghai Jiao Tong University as the first author organization) titled “TMEFF1 is a neuron-specific restriction factor for herpes simplex virus”. They identified TMEFF1, expressed specifically in neur...

Another research finding, concluded as led by Prof. LU Shun, was published in The New England Journal of Medicine. Prof. LU proposed a dual-drug therapy, opening up a new paradigm for the treatment of lung cancers